SEC Form 4 · accession 0001437749-17-006401
LIFECORE BIOMEDICAL, INC. \DE\ · LFCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven P Bitler
Officer — Vice President, Technology
Period of report
Apr 7, 2017
Accepted (ET)
Apr 11, 2017 · 11:43 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005286
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 7, 2017 | M | 17,000 | $5.63 | A | 76,382 | I | Held By Trust |
| Common Stock | Apr 7, 2017 | F | 6,716 | $14.25 | D | 69,666 | I | Held in Trust |
| Common Stock | Apr 7, 2017 | M | 8,000 | $5.63 | A | 77,666 | I | Held By Trust |
| Common StockF1 | Apr 7, 2017 | S | 8,000 | $13.58 | D | 69,666 | I | Held in Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (Right to Buy) | $5.63 | Apr 7, 2017 | M | 17,000 | D | Jun 26, 2010 | May 26, 2017 | Common Stock | 17,000 | 28,000 | I |
| Incentive Stock Option (Right to Buy) | $5.63 | Apr 7, 2017 | M | 8,000 | D | Jun 26, 2010 | May 26, 2017 | Common Stock | 8,000 | 20,000 | I |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.50 to $13.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.